ENSG:NSD-The Ensign Group Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 143.49

Change

0.00 (0.00)%

Market Cap

USD 8.88B

Volume

0.37M

Analyst Target

USD 62.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The company's Skilled Services segment engages in the operation of skilled nursing facilities and rehabilitation therapy services for patients with chronic conditions, prolonged illness, and the elderly; and offers nursing facilities including specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management, as well as standard services comprising room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. Its Standard Bearer segment is comprised of selected real estate properties owned by Standard Bearer and leased to skilled nursing and senior living operators. In addition, the company provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. It operates in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-16 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
OPCH Option Care Health Inc

N/A

USD 4.10B
SGRY Surgery Partners Inc

N/A

USD 3.65B
ACHC Acadia Healthcare Company Inc

N/A

USD 3.51B
AMED Amedisys Inc

N/A

USD 2.95B
LFST Lifestance Health Group Inc

N/A

USD 2.61B
ADUS Addus HomeCare Corporation

N/A

USD 2.17B
ASTH Astrana Health Inc

N/A

USD 1.86B
AVAH Aveanna Healthcare Holdings In..

N/A

USD 1.08B
HCSG Healthcare Services Group Inc

N/A

USD 0.81B
CCRN Cross Country Healthcare Inc

N/A

USD 0.38B

ETFs Containing ENSG

OSCV 2.57 % 0.79 %

N/A

N/A
OASC OneAscent Small Cap Core .. 1.01 % 0.00 %

N/A

USD 0.02B
MWON:XETRA Amundi S&P SmallCap 600 E.. 0.96 % 0.00 %

N/A

USD 0.24B
USASUS:SW Amundi S&P SmallCap 600 E.. 0.96 % 0.00 %

N/A

USD 0.25B
CBUSAS:SW Amundi S&P SmallCap 600 E.. 0.85 % 0.00 %

N/A

N/A
RSSL Global X Funds 0.32 % 0.00 %

N/A

USD 1.43B
ITWO 0.30 % 0.00 %

N/A

N/A
R2US:SW SPDR® Russell 2000 US Sm.. 0.29 % 0.00 %

N/A

USD 4.16B
XRS2:SW Xtrackers Russell 2000 UC.. 0.29 % 0.00 %

N/A

USD 1.54B
FNX First Trust Mid Cap Core .. 0.00 % 0.62 %

N/A

USD 1.25B
FNY First Trust Mid Cap Growt.. 0.00 % 0.70 %

N/A

USD 0.36B
IWO iShares Russell 2000 Grow.. 0.00 % 0.24 %

N/A

N/A
JSMD Janus Henderson Small/Mid.. 0.00 % 0.50 %

N/A

USD 0.38B
OLD 0.00 % 0.50 %

N/A

N/A
RNMC 0.00 % 0.60 %

N/A

N/A
KSCD 0.00 % 0.00 %

N/A

N/A
VRTGX Vanguard Russell 2000 Gro.. 0.00 % 0.00 %

N/A

USD 1.19B
VRTIX Vanguard Russell 2000 Ind.. 0.00 % 0.00 %

N/A

USD 10.02B
SLY 0.00 % 0.15 %

N/A

N/A
SLYG SPDR® S&P 600 Small Cap .. 0.00 % 0.15 %

N/A

N/A
URTY ProShares UltraPro Russel.. 0.00 % 0.95 %

N/A

USD 0.41B
VIOO Vanguard S&P Small-Cap 60.. 0.00 % 0.15 %

N/A

N/A
VTWG Vanguard Russell 2000 Gro.. 0.00 % 0.20 %

N/A

USD 0.99B
VTWO Vanguard Russell 2000 Ind.. 0.00 % 0.15 %

N/A

USD 11.56B
IDP6:LSE iShares S&P SmallCap 600 .. 0.00 % 0.00 %

N/A

N/A
R2SC:LSE SPDR® Russell 2000 US Sm.. 0.00 % 0.00 %

N/A

USD 3.41B
R2US:LSE SPDR® Russell 2000 US Sm.. 0.00 % 0.00 %

N/A

USD 3.41B
RTWO:LSE L&G Russell 2000 US Small.. 0.00 % 0.00 %

N/A

USD 0.15B
RTWP:LSE Legal & General UCITS ETF.. 0.00 % 0.00 %

N/A

USD 0.15B
XRSG:LSE Xtrackers Russell 2000 UC.. 0.00 % 0.00 %

N/A

USD 1.52B
XRSU:LSE Xtrackers Russell 2000 UC.. 0.00 % 0.00 %

N/A

USD 1.52B
R2US:PA SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 3.41B
IUS3:F iShares S&P Small Cap 600.. 0.00 % 0.00 %

N/A

N/A
XRS2:F Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

N/A

USD 1.19B
ZPRR:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 2.91B
ETLZ:XETRA L&G Russell 2000 US Small.. 0.00 % 0.00 %

N/A

USD 0.09B
IUS3:XETRA iShares S&P Small Cap 600.. 0.00 % 0.00 %

N/A

N/A
XRS2:XETRA Xtrackers Russell 2000 UC.. 0.00 % 0.00 %

N/A

USD 1.19B
ZPRR:XETRA SPDR® Russell 2000 US Sm.. 0.00 % 0.00 %

N/A

USD 2.91B
SMLE 0.00 % 0.00 %

N/A

N/A
DFAS Dimensional U.S. Small Ca.. 0.00 % 0.00 %

N/A

USD 8.99B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 27.88% 88% B+ 82% B
Dividend Return 0.21% 100% F 2% F
Total Return 28.09% 88% B+ 81% B-
Trailing 12 Months  
Capital Gain 33.62% 88% B+ 76% C+
Dividend Return 0.28% 100% F 2% F
Total Return 33.90% 88% B+ 75% C
Trailing 5 Years  
Capital Gain 249.46% 90% A- 93% A
Dividend Return 2.83% 50% F 8% B-
Total Return 252.29% 90% A- 93% A
Average Annual (5 Year Horizon)  
Capital Gain 30.69% 77% C+ 80% B-
Dividend Return 30.99% 77% C+ 80% B-
Total Return 0.30% 50% F 12% F
Risk Return Profile  
Volatility (Standard Deviation) 40.13% 50% F 47% F
Risk Adjusted Return 77.23% 100% F 90% A-
Market Capitalization 8.88B 100% F 92% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.